Skip to main content

Table 2 Stratification analyses the association between polymorphisms in TGF-BR1 and gastric cancer risk

From: Polymorphisms of TGFBR1, TLR4 are associated with prognosis of gastric cancer in a Chinese population

Genotype

Age

Gender

H. pylori infection

≤ 64

> 64

Male

Female

Positive

Negative

Ca/Co

OR (95% CI)a

p value

Ca/Co

OR (95% CI)a

p value

Ca/Co

OR (95% CI)a

p value

Ca/Co

OR (95% CI)a

p value

Ca/Co

OR (95% CI)a

p value

Ca/Co

OR (95% CI)a

p value

rs6478974

 TT

100/87

Reference

 

119/107

Reference

 

156/134

Reference

 

63/60

Reference

 

120/91

Reference

 

99/103

Reference

 

 AT

101/113

0.76 (0.51,1.13)

0.175

103/107

0.85 (0.58,1.25)

0.412

159/170

0.80 (0.58,1.10)

0.164

45/50

0.81 (0.46,.41)

0.452

108/107

0.76 (0.52,1.12)

0.160

96/113

0.86 (0.58,1.28)

0.457

 AA

28/30

0.76 (0.41,1.40)

0.374

28/39

0.61 (0.34,1.07)

0.082

38/54

0.55 (0.33,0.90)

0.017

18/15

1.19 (0.55,2.58)

0.663

33/33

0.73 (0.41,1.28)

0.272

23/36

0.62 (0.34,1.14)

0.127

 AT/AA

129/143

0.76 (0.52,1.11)

0.156

131/146

0.80 (0.56,1.14)

0.206

197/224

0.74 (0.54,1.00)

0.049

63/65

0.89 (0.54,1.48)

0.658

141/140

0.75 (0.52,1.08)

0.125

119/149

0.81 (0.55,1.17)

0.260

 Additive model

 

0.83 (0.63,1.10)

0.199

 

0.81 (0.62,1.04)

0.100

 

0.76 (0.61,0.95)

0.016

 

1.01 (0.70,1.44)

0.975

 

0.83 (0.64,1.08)

0.157

 

0.81 (0.62,1.07)

0.135

rs334348

 AA

72/74

Reference

 

71/84

Reference

 

108/121

Reference

 

35/37

Reference

 

77/83

Reference

 

66/75

Reference

 

 AG

105/122

0.95 (0.62,1.47)

0.832

116/118

1.16 (0.77,1.76)

0.478

168/173

1.15 (0.81,1.62)

0.143

53/67

0.85 (0.46,1.54)

0.583

124/100

1.43 (0.94,2.17)

0.093

97/140

0.79 (0.51,1.21)

0.278

 GG

52/34

1.57 (0.90,2.73)

0.114

63/51

1.44 (0.88,2.37)

0.146

77/64

1.37 (0.89,2.11)

0.149

38/21

1.97 (0.94,4.11)

0.072

60/48

0.37 (0.83,2.25)

0.223

55/37

1.71 (0.99,2.53)

0.054

 AG/GG

157/156

1.09 (0.72,1.63)

0.694

179/169

1.26 (0.86,1.85)

0.245

245/237

1.20 (0.87,1.66)

0.269

91/88

1.10 (0.63,1.92)

0.745

184/148

1.40 (0.95,2.06)

0.088

152/177

0.98 (0.66,1.47)

0.927

 Additive model

 

1.21 (0.93,1.59)

0.161

 

1.22 (0.95,1.56)

0.113

 

1.17 (0.95,1.45)

0.141

 

1.36 (0.95,1.94)

0.096

 

1.19 (0.93,1.53)

0.166

 

1.25 (0.96,1.64)

0.097

rs10512263

 TT

130/129

Reference

 

149/133

Reference

 

202/189

Reference

 

77/73

Reference

 

150/127

Reference

 

129/135

Reference

 

 CT

88/88

0.95 (0.64,1.41)

0.814

90/99

0.80 (0.55,1.16)

0.230

136/140

0.89 (0.65,1.22)

0.470

42/47

0.82 (0.48,1.41)

0.471

98/87

0.91 (0.62,1.33)

0.610

80/100

0.83 (0.56,1.22)

0.335

 CC

11/13

0.70 (0.29,1.67)

0.417

11/21

0.44 (0.20,0.96)

0.040

15/29

0.41 (0.21,0.81)

0.010

7/5

1.40 (0.42,4.63)

0.585

13/17

0.64 (0.29,1.39)

0.258

9/17

0.45 (0.19,1.10)

0.080

 CT/CC

99/101

0.91 (0.62,1.33)

0.621

101/120

0.74 (0.52,1.06)

0.101

151/169

0.80 (0.59,1.09)

0.159

49/52

0.87 (0.52,1.46)

0.604

111/104

0.86 (0.60,1.23)

0.405

89/117

0.77 (0.53,1.13)

0.180

 Additive model

 

0.88 (0.64,1.21)

0.441

 

0.74 (0.55,0.99)

0.040

 

0.76 (0.60,0.98)

0.033

 

0.96 (0.63,1.48)

0.864

 

0.85 (0.63,1.14)

0.272

 

0.76 (0.56,1.04)

0.083

  1. Italic represents any values with p < 0.05
  2. OR odds ratio, Ca case, Co control
  3. aAdjusted for age, gender, smoking, drinking, and H. pylori infection status